Search results
ANI Pharmaceuticals bolsters rare disease business with $381M acquisition
Star Tribune (Minneapolis) via Yahoo Finance· 5 hours agoANI Pharmaceuticals is doubling down on its rare diseases business — deemed its biggest driver of...
Obesity drugs from Altimmune, Hengrui show potential; Lilly details Zepbound sleep apnea data
BioPharma Dive via Yahoo Finance· 10 hours ago... investigators described the shot as “well-tolerated,” although early data cuts had revealed that...
Alimera Sciences shares jump by 77% after being acquired by ANI
Pharmaceutical Technology via Yahoo Finance· 7 hours agoANI Pharmaceuticals is broadening its reach into the rare disease space through an acquisition of...
Jazz Pharmaceuticals’ tremor drug fails to meet main goal in mid-stage study
WSAU Wausau· 4 days ago(Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a neurological condition that causes involuntary and rhythmic shaking failed ...
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong...
Insider Monkey via Yahoo Finance· 8 hours agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...
Sun Pharma’s Phase I GL0034 study shows weight loss efficacy and lipid reduction
Clinical Trials Arena via Yahoo Finance· 7 hours agoDanish company Novo Nordisk recently reported DKr61bn ($8.7bn) in sales from...loss, Zealand Pharma...
ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential
Pharmaceutical Technology via Yahoo Finance· 7 hours agoAltimmune is currently investigating the drug for the treatment of MASH in the ongoing Phase IIb...
Alnylam Shares Soar After Drug Meets Goal in Heart Disease Trial
Bloomberg· 12 hours agoHave a confidential tip for our reporters? Alnylam Pharmaceuticals Inc. shares soared after its drug...
Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster
Market Watch· 9 hours agojumped nearly 40% premarket on Monday after the company released results of a late-stage trial for a...
Alnylam Pharma Shares Surge 30% After Rare Heart Disease Drug Succeeds
Forbes· 18 hours agoShares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in nearly...